Structures by: Ramesh P.
Total: 63
5-bromo-3-hydroxy 3-(3-oxopentylindolin-2-one
C13H14BrNO3
RSC Adv. (2015)
a=7.5781(13)Å b=13.148(2)Å c=14.903(3)Å
α=71.939(3)° β=78.573(4)° γ=82.292(4)°
3-hydroxy-5-methoxy-3-(2-oxocyclohexyl)indolin-2-one
C15H17NO4
RSC Adv. (2015)
a=7.5260(7)Å b=15.1059(14)Å c=24.110(2)Å
α=90° β=96.277(2)° γ=90°
Chlorotriphenylphosphine-bis(N- diphenyl(carbamothioyl)benzamide)copper(i)
C58H47ClCuN4O2PS2,H2O
Dalton transactions (Cambridge, England : 2003) (2011) 40, 46 12519-12526
a=21.1426(15)Å b=10.4879(8)Å c=25.0570(17)Å
α=90.00° β=108.708(3)° γ=90.00°
Chloro-bis(triphenylphosphine)-(N- diethyl(carbamothioyl)benzamide)copper(i)
C48H46ClCuN2OP2S
Dalton transactions (Cambridge, England : 2003) (2011) 40, 46 12519-12526
a=10.1804(6)Å b=19.6686(12)Å c=22.4500(14)Å
α=90.00° β=101.886(3)° γ=90.00°
6-[(4-Bromophenylimino)methyl]-1,3-dimethyl-7-(2-methylpropenyl)-1,7- dihydro-pyrrolo[2,3-d]pyrimidine-2,4-dione
C20H21BrN4O2
Acta Crystallographica Section E (2007) 63, 10 o4108-o4108
a=9.202(3)Å b=9.989(3)Å c=10.454(4)Å
α=87.363(19)° β=80.67(2)° γ=84.187(19)°
1,3-Dihydroindole-2-one spiro [3.2']- (2E)-3-(4-methyl-1, 3-thiazole-5-yl)-1-[1-(4-methyl-1,3-thiazol-5-yl)hexahydro- 1H-pyrrolizin-2-yl]prop-2-en-1-one
C25H24N4O2S2
Acta Crystallographica Section E (2007) 63, 10 o4106-o4107
a=10.8362(3)Å b=9.0056(2)Å c=24.7698(5)Å
α=90.00° β=95.2720(10)° γ=90.00°
(2E)-4-(2-chlorophenyl)-1-[(spiro-3'-indolino)-1-(2- chlorophenyl)decahydro-1H-pyrrolo[1,2-a]indol-2-yl]but-2-en-1-one
C33H30Cl2N2O2
Acta Crystallographica Section E (2007) 63, 12 o4851-o4851
a=24.8293(16)Å b=9.6387(6)Å c=24.0094(17)Å
α=90.00° β=100.912(3)° γ=90.00°
Dichlorido(dimethylglyoximato-κ^2^<i>N</i>,<i>N</i>)(dimethylglyoxime-κ^2^<i>N</i>,<i>N</i>')cobalt(III)
C8H15Cl2CoN4O4
Acta Crystallographica Section E (2008) 64, 2 m300-m301
a=8.1901(2)Å b=8.1261(2)Å c=10.4463(3)Å
α=90.00° β=102.0070(10)° γ=90.00°
3-(4-Methylphenyl)-1-[(E)-1-(4-methylphenyl)-3-oxo-1-propenyl]-1H-pyrazole -4-carbaldehyde
C21H18N2O2
Acta Crystallographica Section E (2008) 64, 10 o1889
a=10.2914(4)Å b=15.3618(5)Å c=11.0271(4)Å
α=90.00° β=98.7780(10)° γ=90.00°
3-(Cyclohexylsulfanyl)-2-(4-methylphenyl)-5,7-dinitro-1H-indole
C21H21N3O4S
Acta Crystallographica Section E (2008) 64, 10 o1890
a=6.1009(3)Å b=8.5237(4)Å c=19.1522(10)Å
α=83.551(3)° β=84.184(3)° γ=81.157(2)°
4-(2,4-Dichlorophenyl)-2-(1H-indol-3-yl)-6-methoxypyridine-3,5- dicarbonitrile
C22H12Cl2N4O
Acta Crystallographica Section E (2008) 64, 10 o1892
a=9.5394(2)Å b=10.0358(2)Å c=11.1739(3)Å
α=111.9940(10)° β=97.3030(10)° γ=93.7150(10)°
Methyl 2-benzyl-5-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]-4-nitro-3-phenylpyrrolidine-2-carboxylate
C35H33N3O6
Acta Crystallographica Section E (2008) 64, 10 o1993
a=10.1727(2)Å b=10.4210(2)Å c=15.1680(3)Å
α=91.8330(10)° β=106.1540(10)° γ=102.5360(10)°
Ethyl-1-(4-chlorophenyl)-2-nitro-3-[4-oxo-3-phenyl-1-(4-methoxyphenyl) azetidine-2-yl]-2,3,10,10a-tetrahydro-1H, 5H-pyrrolo[1,2-b] isoquinoline-10a- carboxylate
C37H34ClN3O6
Acta Crystallographica Section E (2008) 64, 10 o2042
a=9.1723(2)Å b=18.0452(4)Å c=19.7475(5)Å
α=90.00° β=100.6380(10)° γ=90.00°
Ethyl 3-phenyl-4-[(<i>Z</i>)-3-phenylacryloyl]5-(3,4,5-trimethoxyphenyl)-pyrrolidine-2-carboxylate
C31H33NO6
Acta Crystallographica Section E (2007) 63, 12 o4873-o4873
a=13.7016(5)Å b=23.1680(9)Å c=8.5695(2)Å
α=90.00° β=90.00° γ=90.00°
(E)-3-(4-Methylphenyl)-3-[3-(4-methylphenyl)-1H-pyrazol-1-yl]-2-propenal
C20H18N2O
Acta Crystallographica Section E (2008) 64, 11 o2243
a=10.0560(9)Å b=10.0786(8)Å c=10.3176(9)Å
α=62.040(4)° β=79.356(4)° γ=63.038(4)°
Ethyl 4'-ethenyl-2'-oxo-4-phenyl-2-(3,4,5-trimethoxyphenyl)spiro[pyrrolidine-3,3'-indoline]-5-carboxylate monohydrate
C31H32N2O6,H2O
Acta Crystallographica Section E (2008) 64, 11 o2052-o2053
a=38.8029(10)Å b=38.8029(10)Å c=11.0307(3)Å
α=90.00° β=90.00° γ=120.00°
4-(2,4-Dichlorophenyl)-1,4-dihydro-2-(1H-indol-3-yl)-6-(pyridine-3- carbonitrile
C25H16Cl2N4
Acta Crystallographica Section E (2008) 64, 10 o1891
a=8.0158(9)Å b=10.0261(12)Å c=14.3653(17)Å
α=72.260(6)° β=79.420(6)° γ=78.224(6)°
Indane-1,3-dione Spiro(2,2')-4'-methoxy carbonyl 3'-(2-hydroxy-indane-1,3-dione) pyrrolizidine
C26H21NO7
Acta Crystallographica Section E (2007) 63, 8 o3610-o3610
a=39.580(5)Å b=7.6690(15)Å c=14.868(3)Å
α=90.00° β=103.291(16)° γ=90.00°
Methyl 1'-(3-hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)-2-oxo-2,3-dihydro-1H-indole-3-spiro-3'-pyrrolizidine-1'-carboxylate
C24H23N3O5
Acta Crystallographica Section E (2007) 63, 8 o3625-o3626
a=13.0337(11)Å b=7.9573(6)Å c=19.9303(17)Å
α=90.00° β=93.184(3)° γ=90.00°
1-(2,4-Dinitrophenyl)-3-(4-methylphenyl)-4-phenylsulfanyl-1<i>H</i>-pyrazole
C22H16N4O4S
Acta Crystallographica Section E (2008) 64, 11 o2093
a=7.3802(3)Å b=26.6996(11)Å c=10.6691(4)Å
α=90.00° β=106.733(2)° γ=90.00°
4-(4-Chlorophenylsulfanyl)-1-[(<i>E</i>)-2-(4-chlorophenylsulfanyl)-1-phenylethenyl]-3-phenyl-1<i>H</i>-pyrazole
C29H20Cl2N2S2
Acta Crystallographica Section E (2008) 64, 11 o2054-o2055
a=12.3808(4)Å b=21.4667(7)Å c=10.4281(4)Å
α=90.00° β=108.181(2)° γ=90.00°
3'-Benzyloxy-3-hydroxy-3,3'-bi-1<i>H</i>-indole-2,2'(3<i>H</i>,3'<i>H</i>)-dione monohydrate
C23H18N2O4,H2O
Acta Crystallographica Section E (2009) 65, 5 o994
a=9.8243(3)Å b=9.9304(6)Å c=11.4460(5)Å
α=107.517(2)° β=114.227(3)° γ=93.918(2)°
4-(4-Chlorophenyl)-6-methoxy-2,2'-bipyridine-5-carbonitrile
C18H12ClN3O
Acta Crystallographica Section E (2009) 65, 5 o995
a=9.5869(5)Å b=13.8761(7)Å c=12.2124(6)Å
α=90.00° β=106.896(2)° γ=90.00°
4-(2, 4-Dichlorophenyl)-6-(1H-indol-3-yl)-2,2'-bipyridine-5-carbonitrile
C25H14Cl2N4
Acta Crystallographica Section E (2009) 65, 5 o996-o997
a=10.0307(12)Å b=22.446(3)Å c=17.932(3)Å
α=90.00° β=90.991(4)° γ=90.00°
5-Chloroacetyl-4-methyl-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepin-2-one
C12H13ClN2O2
Acta Crystallographica Section E (2009) 65, 10 o2361
a=16.7656(4)Å b=8.8171(2)Å c=17.0125(4)Å
α=90.00° β=105.8030(10)° γ=90.00°
4-Methyl-2-oxo-2,3,4,5-tetrahydro-1<i>H</i>-1,5-benzodiazepine-5-carbaldehyde
C11H12N2O2
Acta Crystallographica Section E (2009) 65, 10 o2362
a=5.32840(10)Å b=12.9387(4)Å c=14.6227(5)Å
α=90.00° β=97.968(2)° γ=90.00°
(Benzylamine)chloridobis(ethane-1,2-diamine)cobalt(III) dichloride hemihydrate
C11H25ClCoN52,2(Cl),0.5(H2O)
Acta Crystallographica Section E (2009) 65, 10 m1174-m1175
a=20.9361(9)Å b=7.2447(3)Å c=24.4340(9)Å
α=90.00° β=106.440(2)° γ=90.00°
4-(4-Bromophenyl)-6-(1<i>H</i>-indol-3-yl)-2,2'-bipyridine-5-carbonitrile
C25H15BrN4
Acta Crystallographica Section E (2009) 65, 3 o450
a=14.7393(4)Å b=10.7465(3)Å c=25.4251(7)Å
α=90.00° β=90.00° γ=90.00°
2-(1<i>H</i>-indol-3-ylcarbonyl)acetonitrile
C11H8N2O
Acta Crystallographica Section E (2009) 65, 3 o447
a=7.3439(2)Å b=7.3534(2)Å c=18.2475(5)Å
α=83.402(2)° β=78.890(2)° γ=73.5010(10)°
Diethyl 1,1-dioxo-3,5-bis(pyridin-2-yl)-1λ^6^,4-thiomorpholine-2,6-dicarboxylate
C20H23N3O6S
Acta Crystallographica Section E (2011) 67, 2 o305
a=20.7258(13)Å b=8.3921(5)Å c=24.4923(15)Å
α=90.00° β=90.00° γ=90.00°
1-chloroacetyl-2,6-bis(2-chlorophenyl)-3,5-dimethyl-piperidin-4-one oxime
C21H21Cl3N2O2
Acta Crystallographica Section E (2010) 66, 6 o1506
a=9.8147(6)Å b=15.5929(11)Å c=13.9498(9)Å
α=90.00° β=93.529(4)° γ=90.00°
1-Formyl-<i>t</i>-3,<i>t</i>-5-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C20H21NO2
Acta Crystallographica Section E (2010) 66, 6 o1505
a=7.4303(4)Å b=15.3567(6)Å c=29.6732(13)Å
α=90.00° β=90.00° γ=90.00°
1-(Dicyanomethylene)-2,3,4-tetrahydrocarbazole
C15H11N3
Acta Crystallographica Section E (2010) 66, 11 o2965
a=7.7631(10)Å b=8.0003(10)Å c=9.8933(13)Å
α=87.461(8)° β=82.392(8)° γ=75.038(7)°
2-Methoxyquinoline-3-carbaldehyde
C11H9NO2
Acta Crystallographica Section E (2010) 66, 10 o2510
a=8.8206(6)Å b=4.8446(3)Å c=21.6828(14)Å
α=90.00° β=90.612(4)° γ=90.00°
3-phenyl-1<i>H</i>-pyrazole
C29H34N2S2
Acta Crystallographica Section E (2008) 64, 11 o2132-o2133
a=6.3859(5)Å b=19.1596(17)Å c=21.337(2)Å
α=90.00° β=90.00° γ=90.00°
1-Acetyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C21H23NO2
Acta Crystallographica Section E (2009) 65, 8 o1974
a=7.5622(4)Å b=10.6369(5)Å c=11.1497(7)Å
α=90.00° β=100.373(3)° γ=90.00°
1-Benzoyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C26H25NO2
Acta Crystallographica Section E (2009) 65, 8 o1975
a=10.8540(9)Å b=17.8050(17)Å c=10.8853(10)Å
α=90.00° β=94.987(3)° γ=90.00°
1N-Methyl-3,3-dicarbonitrile-4,5-dispirooxindolinpyrrolidine
C21H15N5O2
Acta Crystallographica Section E (2009) 65, 8 o1945
a=13.3173(3)Å b=9.9480(2)Å c=13.3950(3)Å
α=90.00° β=91.8270(10)° γ=90.00°
3-(4-Chlorophenyl)-1-[(<i>E</i>)-1-(4-chlorophenyl)-2-(4-methylphenylsulfanyl)ethenyl]-4-(4-methylphenylsulfanyl)-1<i>H</i>-pyrazole
C31H24Cl2N2S2
Acta Crystallographica Section E (2009) 65, 11 o2881-o2882
a=9.7515(2)Å b=10.2097(3)Å c=27.6705(6)Å
α=90.00° β=96.4020(10)° γ=90.00°
Chloridobis(ethane-1,2-diamine)(4-methylaniline)cobalt(III) dichloride monohydrate
C11H25ClCoN52,2(Cl),H2O
Acta Crystallographica Section E (2009) 65, 11 m1458-m1459
a=7.3796(2)Å b=10.8367(3)Å c=12.1789(3)Å
α=75.2010(10)° β=74.671(2)° γ=78.8620(10)°
1-Chloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one
C22H24ClNO4
Acta Crystallographica Section E (2009) 65, 11 o2883
a=8.9147(8)Å b=11.9648(10)Å c=19.1365(16)Å
α=99.729(5)° β=93.665(5)° γ=90.112(6)°
<i>c</i>-3,<i>t</i>-3-Dimethyl-<i>r</i>-2,<i>c</i>-7-diphenyl-1,4-diazepan-5-one
C19H22N2O
Acta Crystallographica Section E (2009) 65, 11 o2884
a=6.7354(4)Å b=10.6867(6)Å c=11.4186(7)Å
α=82.191(3)° β=88.218(4)° γ=80.317(3)°
<i>t</i>-3-Ethyl-<i>r</i>-2,<i>c</i>-7-bis(4-methoxyphenyl)-1,4-diazepan-5-one
C21H26N2O3
Acta Crystallographica Section E (2009) 65, 11 o2885-o2886
a=10.5190(3)Å b=13.3480(4)Å c=15.0472(4)Å
α=102.118(2)° β=93.662(2)° γ=110.287(2)°
(E)-3-(4-bromophenyl)-3-[3-(4-bromophenyl)-1H-pyrazol-1-yl]-2-propenal
C18H12Br2N2O
Acta Crystallographica Section E (2010) 66, 2 o279
a=9.2600(3)Å b=9.3782(3)Å c=37.9965(4)Å
α=90.00° β=90.00° γ=90.00°
1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3,<i>t</i>-5-dimethylpiperidin-4-one
C23H25Cl2NO4
Acta Crystallographica Section E (2010) 66, 2 o263
a=8.1251(7)Å b=9.9702(9)Å c=27.649(2)Å
α=90.00° β=92.265(5)° γ=90.00°
1-Chloroacetyl-3-isopropyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C22H24ClNO2
Acta Crystallographica Section E (2010) 66, 2 o276-o277
a=10.3415(12)Å b=9.0243(9)Å c=21.438(2)Å
α=90.00° β=90.894(3)° γ=90.00°
1-Dichloroacetyl-<i>r</i>-2,<i>c</i>-6-bis(4-methoxyphenyl)-<i>t</i>-3-methylpiperidin-4-one
C22H23Cl2NO4
Acta Crystallographica Section E (2010) 66, 2 o262
a=19.3021(16)Å b=10.5886(9)Å c=10.3241(10)Å
α=90.00° β=91.445(5)° γ=90.00°
C37H35N3O6
C37H35N3O6
Acta Crystallographica Section E (2010) 66, 3 o646
a=9.3039(3)Å b=13.0725(3)Å c=13.8814(3)Å
α=87.5040(10)° β=74.1230(10)° γ=74.9260(10)°
1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-{[2'-(2-ethyl-2<i>H</i>-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-oxo-2,3-dihydro-1<i>H</i>-benzimidazole-4-carboxylate
C33H34N6O6
Acta Crystallographica Section E (2010) 66, 4 o998
a=16.3770(7)Å b=8.5928(4)Å c=43.7733(19)Å
α=90.00° β=91.1500(10)° γ=90.00°
4-<i>tert</i>-Butylpyridinium picrate
C9H14N,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 4 o999
a=5.7669(12)Å b=26.798(6)Å c=11.195(3)Å
α=90.00° β=97.335(6)° γ=90.00°
4-Aminopyridinium picrate
C5H7N2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 4 o1000
a=8.5056(7)Å b=11.3338(9)Å c=14.3307(11)Å
α=90.00° β=104.162(5)° γ=90.00°
4-Hydroxy-3-(1'-methyl-2-oxo-4'-phenylspiro[indoline-3,2'-pyrrolidine]-3-ylcarbonyl)quinolin-2(1<i>H</i>)-one
C28H23N3O4
Acta Crystallographica Section E (2010) 66, 4 o952
a=9.6918(3)Å b=11.0258(3)Å c=12.9663(4)Å
α=69.1110(10)° β=72.044(2)° γ=66.4100(10)°
Benzamide picric acid (1:1) adduct
C7H7NO,C6H3N3O7
Acta Crystallographica Section E (2010) 66, 7 o1820
a=7.8644(3)Å b=7.0664(3)Å c=25.6580(10)Å
α=90.00° β=90.978(4)° γ=90.00°
8-Methoxy-3,3,5-trimethyl-3,11-dihydropyrano[3,2-<i>a</i>]carbazole
C19H19NO2
Acta Crystallographica Section E (2010) 66, 7 o1581
a=8.290(5)Å b=8.693(5)Å c=21.326(5)Å
α=90.000(5)° β=90.742(5)° γ=90.000(5)°
2-Aminopyridinium picrate
C5H7N2,C6H2N3O7
Acta Crystallographica Section E (2010) 66, 7 o1821
a=11.2543(4)Å b=11.6588(5)Å c=12.9883(5)Å
α=114.641(4)° β=100.204(3)° γ=103.928(3)°
({[(Carboxymethyl)sulfanyl](2-hydroxyphenyl)methyl}sulfanyl)acetic acid
C11H12O5S2
Acta Crystallographica Section E (2013) 69, 6 o893
a=7.24650(10)Å b=7.65330(10)Å c=12.0141(2)Å
α=101.094(2)° β=99.1290(10)° γ=102.390(2)°
2-(6-Methyl-1,2,3,4-Tetrahydro-9H-carbazol-1-ylidene)propanedinitrile
C16H13N3
Acta Crystallographica Section E (2011) 67, 12 o3270
a=7.6396(9)Å b=8.4381(8)Å c=10.8967(13)Å
α=88.395(6)° β=71.392(7)° γ=71.217(6)°
2-(6-Chloro-2,3,4,9-tetrahydro-1<i>H</i>-carbazol-1-ylidene)propanedinitrile
C15H10ClN3
Acta Crystallographica Section E (2011) 67, 12 o3268
a=7.5731(3)Å b=7.6865(3)Å c=22.2867(8)Å
α=90.00° β=97.437(2)° γ=90.00°
6-Bromo-2-(3-phenylallylidene)-2,3,4,9-tetrahydro-1<i>H</i>-carbazol-1-one
C21H16BrNO
Acta Crystallographica Section E (2011) 67, 12 o3269
a=17.3682(7)Å b=14.9974(8)Å c=6.6861(3)Å
α=90.00° β=92.226(2)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-2-Chlorobenzylidene]-2-[(1,3,4-thiadiazol-2-yl)sulfanyl]acetohydrazide
C11H9ClN4OS2
Acta Crystallographica Section E (2011) 67, 10 o2612
a=7.551(5)Å b=8.743(3)Å c=11.269(5)Å
α=69.295(5)° β=87.493(4)° γ=78.892(5)°
1-Formyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C20H21NO2
Acta Crystallographica Section E (2012) 68, 3 o870
a=10.6604(6)Å b=15.7278(7)Å c=10.8066(5)Å
α=90.00° β=110.120(2)° γ=90.00°
C33H28O3
C33H28O3
The Journal of organic chemistry (2019) 84, 20 12856-12870
a=10.19794(19)Å b=17.6415(3)Å c=14.5974(3)Å
α=90° β=104.8742(18)° γ=90°
6-Bromo-2-[(<i>E</i>)-thiophen-2-ylmethylidene]-2,3,4,9-tetrahydro-1<i>H</i>-carbazol-1-one
C17H12BrNOS
Acta Crystallographica Section E (2011) 67, 12 o3271
a=13.8655(5)Å b=6.3081(3)Å c=17.4583(7)Å
α=90.00° β=103.666(2)° γ=90.00°